Back
Cellectar Biosciences Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
CLRB
Cellectar Biosciences
Last Price:
$0.26
Seasonality Move:
-2.17%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.
Cellectar Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.25 | Sell |
| 20-day SMA: | 0.85 | Sell |
| 50-day SMA: | 1.52 | Sell |
| 200-day SMA: | 2.45 | Sell |
| 8-day EMA: | 0.35 | Sell |
| 20-day EMA: | 0.74 | Sell |
| 50-day EMA: | 1.3 | Sell |
| 200-day EMA: | 2.13 | Sell |
Cellectar Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 9.9 | Sell |
| Chaikin Money Flow: | -692809 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.39 - 1.61) | Sell |
| Bollinger Bands (100): | (1.24 - 2.36) | Sell |
Cellectar Biosciences Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cellectar Biosciences Stock
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 0.25 while CLRB 8-day simple moving average is 0.25, which is a Sell signal.
-
The stock price of CLRB is 0.25 while Cellectar Biosciences 20-day SMA is 0.85, which makes it a Sell.
-
Cellectar Biosciences 50-day simple moving average is 1.52 while CLRB share price is 0.25, making it a Sell technically.
-
CLRB stock price is 0.25 and Cellectar Biosciences 200-day simple moving average is 2.45, creating a Sell signal.
CLRB Technical Analysis vs Fundamental Analysis
Sell
38
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy or a Sell?
-
Cellectar Biosciences stock is rated a SellThe current Cellectar Biosciences [CLRB] share price is $0.25. The Score for CLRB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Cellectar Biosciences Stock Info
Market Cap:
10.5M
Price in USD:
0.25
Share Volume:
795.7K
Cellectar Biosciences 52-Week Range
52-Week High:
4.45
52-Week Low:
0.22
Sell
38
Cellectar Biosciences (CLRB)
is a Sell
Cellectar Biosciences Share Price Forecast
-
What is the Cellectar Biosciences stock price today?The Cellectar Biosciences stock price is 0.25 USD today.
-
Will CLRB stock go up or go down?Cellectar Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Cellectar Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cellectar Biosciences is overvalued.
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 0.25 while CLRB 8-day exponential moving average is 0.35, which is a Sell signal.
-
The stock price of CLRB is 0.25 while Cellectar Biosciences 20-day EMA is 0.74, which makes it a Sell.
-
Cellectar Biosciences 50-day exponential moving average is 1.30 while CLRB share price is 0.25, making it a Sell technically.
-
CLRB stock price is 0.25 and Cellectar Biosciences 200-day simple moving average is 2.13, creating a Sell signal.
Fundamental Analysis of Cellectar Biosciences
Is Cellectar Biosciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.26 per share, and an increase next year of $0.89 per share.
Technical Analysis of Cellectar Biosciences
Should I short Cellectar Biosciences stock?
-
CLRB Moving Average Covergence Divergence (MACD) indicator is -0.41, suggesting Cellectar Biosciences is a Sell
-
Cellectar Biosciences Relative Strength Index (RSI) is 9.9, which suggest Cellectar Biosciences is oversold
-
The Bollinger Bands (25) for Cellectar Biosciences is (0.39 - 1.61), which suggest Cellectar Biosciences is a Sell
-
The Bollinger Bands (100) for Cellectar Biosciences is (1.24 - 2.36), which suggest Cellectar Biosciences is a Sell
* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.